GlassScriptPhysician profile
Elinor Amy Berry
NPI 1578664801
$4,287.72
in general payments reported to CMS, 2019-2025
23 companies · $817 in 2025
The $817 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $411 · 2022: $683 · 2023: $1,121 · 2024: $1,255 · 2025: $817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,193.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $891.40 | 2021-2025 | Breztri, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $852.39 | 2021-2025 | Trelegy Ellipta, Nucala |
| Inspire Medical Systems, INC. | $641.00 | 2023-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $317.37 | 2023-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.00 | 2021-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Mylan Specialty L.P. | $173.65 | 2022-2024 | Yupelri |
| Genzyme Corporation | $162.16 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $144.19 | 2022-2025 | Glassia, Hyqvia |
| Amgen INC. | $129.46 | 2021-2024 | Tezspire |
| Jazz Pharmaceuticals INC. | $89.63 | 2022-2025 | |
| Electromed, INC. | $82.50 | 2023-2024 | Smartvest |
| Philips North America LLC | $79.83 | 2023-2024 | (Ak6) Vest Therapy, (6299) Dreamwear |
| Shionogi INC | $61.63 | 2023-2024 | Fetroja |
| United Therapeutics Corporation | $57.06 | 2023-2024 | Tyvaso |
| Merck Sharp & Dohme LLC | $56.07 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $51.63 | 2025 | Ohtuvayre |
| Mallinckrodt Hospital Products INC. | $49.31 | 2024 | Acthar |
| Insmed, INC. | $40.96 | 2022-2024 | Arikayce |
| Axsome Therapeutics, INC. | $39.56 | 2022-2023 | Sunosi |
| Phadia US INC. | $31.43 | 2022 | |
| Viatris Specialty LLC | $25.86 | 2025 | Yupelri |
| Collegium Pharmaceutical, INC. | $23.58 | 2025 | Jornay Pm |
| Novo Nordisk INC | $14.05 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elinor Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.